Subscribe to RSS
Please copy the URL and add it into your RSS Feed Reader.
https://www.thieme-connect.de/rss/thieme/en/10.1055-s-00000084.xml
Synthesis 2010(16): 2749-2758
DOI: 10.1055/s-0029-1218842
DOI: 10.1055/s-0029-1218842
PAPER
© Georg Thieme Verlag
Stuttgart ˙ New York
3-Formylchromones, Acylpyruvates, and Chalcone as Valuable Substrates for the Syntheses of Fused Pyridines
Further Information
Received
9 April 2010
Publication Date:
29 June 2010 (online)
Publication History
Publication Date:
29 June 2010 (online)
Abstract
The reaction of electron-rich aminoheterocycles with 1,3-CCC-dielectrophiles, such as 3-formylchromones, acylpyruvates, and chalcone, provided diversely fused pyridines. Starting from 5-amino-1-(2,3-O-isopropylidene-β-d-ribofuranosyl)-1H-pyrazole, nucleosides containing a pyrazolo[3,4-b]pyridine fragment were obtained, which can be considered as adenosine deaminase (ADA) inhibitors.
Key words
aminoheterocycles - 3-formylchromones - acylpyruvates - chalcone - fused pyridines - annulation reaction - nucleosides
-
1a
Ealick SE,Parker WB,Seerist JA, andSorscher EJ. inventors; WO 2003,035,012. -
1b
Matulic-Adamic J.Takahashi K.Chou TC.Gadler H.Price RW.Watanabe KA.Reddy ARV.Kalman TI. J. Med. Chem. 1988, 31: 1642 -
1c
Hackova D.Hocek M.Dvorakova H.Votruba I. Tetrahedron 1999, 55: 11109 -
1d
Koch M,Den H,Jacobus A,Koomen J,Wanner G.-J,Martinus J, andRoelof FW. inventors; WO 2006,027,365. -
1e
Erion MDM.Reddy R. J. Am. Chem. Soc. 1998, 120: 3295 -
1f
Veliz EA.Stephens OM.Beal PA. Org. Lett. 2001, 3: 2969 -
1g
Lee S.Park SB. Org. Lett. 2009, 11: 5214 - 2
Misra RN.Rawlins DB.Xiao H.Shan W.Bursuker I.Kellar KA.Mulheron JG.Sack JS.Tokarski JS.Kimball SD.Webster KR. Bioorg. Med. Chem. Lett. 2003, 13: 1133 -
3a
Lin R.Connolly PJ.Lu Y.Chiu G.Li S.Yu Y.Huang S.Li X.Emanuel SL.Middleton SA.Gruninger RH.Adams M.Fuentes-Pesquera AR.Greenberger LM. Bioorg. Med. Chem. Lett. 2007, 17: 4297 -
3b
Witherington J.Bordas V.Gaiba A.Garton NS.Naylor A.Rawlings AD.Slingsby BP.Smith DG.Takle AK.Ward RW. Bioorg. Med. Chem. Lett. 2003, 13: 3055 -
4a
Goda FE.Abdel-Azizb AA.-M.Attef OA. Bioorg. Med. Chem. 2004, 12: 1845 -
4b
Foks H.Pancechowska-Ksepko D.Kvdzia A.Zwolska Z.Janowiec M.Augustynowicz-Kopec E. Farmaco 2005, 60: 513 - 5
Dias LRS.Santos MB.de Albuquerque S.Castro HC.de Souza AMT.Freitas ACC.DiVaio MAV.Cabral LM.Rodriguese CR. Bioorg. Med. Chem. 2007, 15: 211 -
6a
de Mello H.Echevarria A.Bernardino AM.Canto-Cavalheiro M.Leon LL. J. Med. Chem. 2004, 47: 5427 -
6b
Bharate SB.Mahajan TR.Gole YR.Nambiar M.Matan TT.Kulkarni-Almeida A.Balachandran S.Junjappa H.Balakrishnan A.Vishwakarma RA. Bioorg. Med. Chem. 2008, 16: 7167 -
7a
Haas G.Stanton JL.von Sprecher A.Wenk P.
J. Heterocycl. Chem. 1981, 18: 607 -
7b
Quiroga J.Mejía D.Insuasty B.Abonía R.Nogueras M.Sánchez A.Cobo J.Low JN. J. Heterocycl. Chem. 2002, 39: 51 -
7c
Ghosh T.Bandyopadhyay C. J. Heterocycl. Chem. 2006, 43: 1431 -
7d
Stankovičová H.Gáplovský A.Lácová M.Chovancová J.Puchaa A. J. Heterocycl. Chem. 2006, 43: 843 -
7e
Chebanov VA.Sakhno YI.Desenko SM.Chernenko VN.Musatov VI.Shishkina SV.Shishkin OV.Kappe CO. Tetrahedron 2007, 63: 1229 -
8a
Ryabukhin SV.Plaskon AS.Volochnyuk DM.Pipko SE.Tolmachev AA. Heterocycles 2008, 75: 583 -
8b
Randhavane PV.Kale SB.Jagdhani SG.Karale BK. Indian J. Heterocycl. Chem. 2007, 17: 153 -
8c
Sonawane SA.Karale BK.Shingare MS. Indian J. Heterocycl. Chem. 2004, 14: 155 -
9a
Plaskon AS.Ryabukhin SV.Volochnyuk DM.Gavrilenko KS.Shivanyuk AN.Tolmachev AA. J. Org. Chem. 2008, 73: 6010 -
9b
Ryabukhin SV.Plaskon AS.Volochnyuk DM.Tolmachev AA. Synthesis 2007, 1861 -
10a
Sosnovskikh VYa.Irgashev RA.Kodess MI. Tetrahedron 2008, 64: 2997 -
10b
Sosnovskikh VYa.Khalymbadzha IA.Irgashev RA.Slepukhin PA. Tetrahedron 2008, 64: 10172 -
11a
Wang X.-S.Zhang M.-M.Li Q.Yao C.-S.Tu S.-J. Synth. Commun. 2008, 38: 1896 -
11b
Shi D.-Q.Ni S.-N.Yang F.Shi J.-W.Dou G.-L.Li X.-Y.Wang X.-S.Ji S.-J. J. Heterocycl. Chem. 2008, 45: 693 - 12
Goswami S.Jana S.Hazra A.Adak AK. J. Heterocycl. Chem. 2007, 44: 1191 - 13
Cho CS.Kim JU. Tetrahedron Lett. 2007, 48: 3775 -
14a
Iaroshenko VO.Wang Y.Sevenard DV.Volochnyuk DM. Synthesis 2009, 1851 -
14b
Iaroshenko VO.Volochnyuk DM.Kryvokhyzha NV.Martyloga A.Sevenard DV.Groth U.Brand J.Chernega AN.Shivanyuk AN.Tolmachev AA. Synthesis 2008, 2337 -
15a
Iaroshenko VO.Sevenard DV.Volochnyuk DM.Wang Y.Martiloga A.Tolmachev AA. Synthesis 2009, 1865 -
15b
Volochnyuk DM.Pushechnikov AO.Krotko DG.Sibgatulin DA.Kovalyova SA.Tolmachev AA. Synthesis 2003, 1531 -
15c
Iaroshenko VO.Sevenard DV.Kotljarov AV.Volochnyuk DM.Tolmachev AA.Sosnovskikh VYa. Synthesis 2009, 731 - 16
Iaroshenko VO.Groth U.Kryvokhyzha NV.Obeid S.Tolmachev AA.Wesch T. Synlett 2008, 343 - 17
Easterwood LM.Véliz EA.Beal PA. J. Am. Chem. Soc. 2000, 122: 11537 -
18a
Véliz EA.Easterwood LM.Beal PA. J. Am. Chem. Soc. 2003, 125: 10867 -
18b
Cristalli G.Eleuteri A.Vittori S.Volpini R.Camaioni E.Lupidi G. Drug Dev. Res. 1993, 28: 253 -
18c
Lupidi G.Marmocchi F.Cristalli G. Biochem. Mol. Biol. 1998, 46: 1071 -
18d
Lupidi G.Cristalli G.Marmocchi F.Riva F.Grifantini M.
J. Enzyme Inhib. Med. Chem. 1985, 1: 67 -
18e
Okamoto A.Tanaka K.Saito I. Bioorg. Med. Chem. Lett. 2002, 12: 97